TY - JOUR AU - Du, X. L. AU - Fox, E. E. AU - Lai, D. PY - 2008 DA - 2008// TI - Competing causes of death for women with breast cancer and change over time from 1975 to 2003 JO - Am J Clin Oncol VL - 31 UR - https://doi.org/10.1097/COC.0b013e318142c865 DO - 10.1097/COC.0b013e318142c865 ID - Du2008 ER - TY - JOUR AU - Gebski, V. AU - Lagleva, M. AU - Keech, A. AU - Simes, J. AU - Langlands, A. O. PY - 2006 DA - 2006// TI - Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective JO - J Natl Cancer Inst VL - 98 UR - https://doi.org/10.1093/jnci/djj002 DO - 10.1093/jnci/djj002 ID - Gebski2006 ER - TY - JOUR AU - Tornberg, S. AU - Kemetli, L. AU - Lynge, E. AU - Helene Olsen, A. AU - Hofvind, S. AU - Wang, H. PY - 2006 DA - 2006// TI - Breast cancer incidence and mortality in the Nordic capitals, 1970–1998. Trends related to mammography screening programmes JO - Acta Oncol VL - 45 UR - https://doi.org/10.1080/02841860500501610 DO - 10.1080/02841860500501610 ID - Tornberg2006 ER - TY - JOUR AU - Anders, C. AU - Carey, L. A. PY - 2008 DA - 2008// TI - Understanding and treating triple-negative breast cancer JO - Oncology VL - 22 ID - Anders2008 ER - TY - JOUR AU - Lehmann, B. D. AU - Jovanović, B. AU - Chen, X. AU - Estrada, M. V. AU - Johnson, K. N. AU - Shyr, Y. PY - 2016 DA - 2016// TI - Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0157368 DO - 10.1371/journal.pone.0157368 ID - Lehmann2016 ER - TY - JOUR AU - Pogoda, K. AU - Niwińska, A. AU - Murawska, M. AU - Pieńkowski, T. PY - 2013 DA - 2013// TI - Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients JO - Med Oncol VL - 30 UR - https://doi.org/10.1007/s12032-012-0388-4 DO - 10.1007/s12032-012-0388-4 ID - Pogoda2013 ER - TY - JOUR AU - Linklater, E. S. AU - Tovar, E. A. AU - Essenburg, C. J. AU - Turner, L. AU - Madaj, Z. AU - Winn, M. E. PY - 2016 DA - 2016// TI - Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers JO - Oncotarget VL - 7 ID - Linklater2016 ER - TY - JOUR AU - Gray, M. J. AU - Gong, J. AU - Hatch, M. M. AU - Nguyen, V. AU - Hughes, C. C. AU - Hutchins, J. T. PY - 2016 DA - 2016// TI - Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers JO - Breast Cancer Res VL - 18 UR - https://doi.org/10.1186/s13058-016-0708-2 DO - 10.1186/s13058-016-0708-2 ID - Gray2016 ER - TY - JOUR AU - Krol, J. AU - Loedige, I. AU - Filipowicz, W. PY - 2010 DA - 2010// TI - The widespread regulation of microRNA biogenesis, function and decay JO - Nat Rev Genet VL - 11 ID - Krol2010 ER - TY - JOUR AU - Zhang, B. AU - Pan, X. AU - Cobb, G. P. AU - Anderson, T. A. PY - 2007 DA - 2007// TI - microRNAs as oncogenes and tumor suppressors JO - Dev Biol VL - 302 UR - https://doi.org/10.1016/j.ydbio.2006.08.028 DO - 10.1016/j.ydbio.2006.08.028 ID - Zhang2007 ER - TY - JOUR AU - Ma, L. AU - Teruya-Feldstein, J. AU - Weinberg, R. A. PY - 2007 DA - 2007// TI - Tumour invasion and metastasis initiated by microRNA-10b in breast cancer JO - Nature VL - 449 UR - https://doi.org/10.1038/nature06174 DO - 10.1038/nature06174 ID - Ma2007 ER - TY - JOUR AU - Gabriely, G. AU - Teplyuk, N. M. AU - Krichevsky, A. M. PY - 2011 DA - 2011// TI - Context effect: microRNA-10b in cancer cell proliferation, spread and death JO - Autophagy VL - 7 UR - https://doi.org/10.4161/auto.7.11.17371 DO - 10.4161/auto.7.11.17371 ID - Gabriely2011 ER - TY - JOUR AU - Huang, T. H. AU - Wu, F. AU - Loeb, G. B. AU - Hsu, R. AU - Heidersbach, A. AU - Brincat, A. PY - 2009 DA - 2009// TI - Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion JO - J Biol Chem VL - 284 UR - https://doi.org/10.1074/jbc.M109.006676 DO - 10.1074/jbc.M109.006676 ID - Huang2009 ER - TY - JOUR AU - Han, M. AU - Wang, Y. AU - Liu, M. AU - Bi, X. AU - Bao, J. AU - Zeng, N. PY - 2012 DA - 2012// TI - MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells JO - Cancer Sci VL - 103 UR - https://doi.org/10.1111/j.1349-7006.2012.02281.x DO - 10.1111/j.1349-7006.2012.02281.x ID - Han2012 ER - TY - JOUR AU - Zhang, C. M. AU - Zhao, J. AU - Deng, H. Y. PY - 2013 DA - 2013// TI - MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1 JO - J Biomed Sci VL - 20 UR - https://doi.org/10.1186/1423-0127-20-79 DO - 10.1186/1423-0127-20-79 ID - Zhang2013 ER - TY - JOUR AU - Ferracin, M. AU - Bassi, C. AU - Pedriali, M. AU - Pagotto, S. AU - D’Abundo, L. AU - Zagatti, B. PY - 2013 DA - 2013// TI - miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression JO - Mol Cancer VL - 12 UR - https://doi.org/10.1186/1476-4598-12-130 DO - 10.1186/1476-4598-12-130 ID - Ferracin2013 ER - TY - JOUR AU - Volinia, S. AU - Galasso, M. AU - Sana, M. E. AU - Wise, T. F. AU - Palatini, J. AU - Huebner, K. PY - 2012 DA - 2012// TI - Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA JO - Proc Natl Acad Sci USA VL - 109 UR - https://doi.org/10.1073/pnas.1200010109 DO - 10.1073/pnas.1200010109 ID - Volinia2012 ER - TY - JOUR AU - Sun, L. AU - Wang, Q. AU - Gao, X. AU - Shi, D. AU - Mi, S. AU - Han, Q. PY - 2015 DA - 2015// TI - MicroRNA-454 functions as an oncogene by regulating PTEN in uveal melanoma JO - FEBS Lett VL - 589 UR - https://doi.org/10.1016/j.febslet.2015.08.007 DO - 10.1016/j.febslet.2015.08.007 ID - Sun2015 ER - TY - JOUR AU - Liu, L. AU - Nie, J. AU - Chen, L. AU - Dong, G. AU - Du, X. AU - Wu, X. PY - 2013 DA - 2013// TI - The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0055532 DO - 10.1371/journal.pone.0055532 ID - Liu2013 ER - TY - JOUR AU - Zhu, D. Y. AU - Li, X. N. AU - Qi, Y. AU - Liu, D. L. AU - Yang, Y. AU - Zhao, J. PY - 2016 DA - 2016// TI - MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN JO - Biomed Pharmacother VL - 81 UR - https://doi.org/10.1016/j.biopha.2016.03.029 DO - 10.1016/j.biopha.2016.03.029 ID - Zhu2016 ER - TY - JOUR AU - Yu, L. AU - Gong, X. AU - Sun, L. AU - Yao, H. AU - Lu, B. AU - Zhu, L. PY - 2015 DA - 2015// TI - miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.4407 DO - 10.18632/oncotarget.4407 ID - Yu2015 ER - TY - JOUR AU - Liang, H. L. AU - Hu, A. P. AU - Li, S. L. AU - Xie, J. P. AU - Ma, Q. Z. AU - Liu, J. Y. PY - 2015 DA - 2015// TI - MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression JO - Asian Pac J Cancer Prev VL - 16 UR - https://doi.org/10.7314/APJCP.2015.16.6.2397 DO - 10.7314/APJCP.2015.16.6.2397 ID - Liang2015 ER - TY - JOUR AU - Cao, Z. G. AU - Li, J. J. AU - Yao, L. AU - Huang, Y. N. AU - Liu, Y. R. AU - Hu, X. PY - 2016 DA - 2016// TI - High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer JO - Oncotarget VL - 7 ID - Cao2016 ER - TY - JOUR AU - Zhang, L. AU - Zhou, Z. AU - Mei, X. AU - Yang, Z. AU - Ma, J. AU - Chen, X. PY - 2015 DA - 2015// TI - Intraoperative radiotherapy versus whole-breast external beam radiotherapy in early-stage breast cancer: a systematic review and meta-analysis JO - Medicine VL - 94 UR - https://doi.org/10.1097/MD.0000000000001143 DO - 10.1097/MD.0000000000001143 ID - Zhang2015 ER - TY - JOUR AU - Abdulkarim, B. S. AU - Cuartero, J. AU - Hanson, J. AU - Deschênes, J. AU - Lesniak, D. AU - Sabri, S. PY - 2011 DA - 2011// TI - Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.33.4714 DO - 10.1200/JCO.2010.33.4714 ID - Abdulkarim2011 ER - TY - JOUR AU - Dent, R. AU - Hanna, W. M. AU - Trudeau, M. AU - Rawlinson, E. AU - Sun, P. AU - Narod, S. A. PY - 2009 DA - 2009// TI - Pattern of metastatic spread in triple-negative breast cancer JO - Breast Cancer Res Treat VL - 115 UR - https://doi.org/10.1007/s10549-008-0086-2 DO - 10.1007/s10549-008-0086-2 ID - Dent2009 ER - TY - JOUR AU - López-Knowles, E. AU - O’Toole, S. A. AU - McNeil, C. M. AU - Millar, E. K. AU - Qiu, M. R. AU - Crea, P. PY - 2010 DA - 2010// TI - PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality JO - Int J Cancer VL - 126 UR - https://doi.org/10.1002/ijc.24831 DO - 10.1002/ijc.24831 ID - López-Knowles2010 ER - TY - JOUR AU - Cully, M. AU - You, H. AU - Levine, A. J. AU - Mak, T. W. PY - 2006 DA - 2006// TI - Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis JO - Nat Rev Cancer VL - 6 UR - https://doi.org/10.1038/nrc1819 DO - 10.1038/nrc1819 ID - Cully2006 ER -